Literature DB >> 22796690

Biliary atresia and cytomegalovirus and response to valganciclovir.

Ira Shah1, Sushmita Bhatnagar.   

Abstract

Biliary atresia has been commonly reported with cytomegalovirus (CMV) infection. CMV positive patients may present with a later onset however long term outcome is similar to non-CMV patients. There are very few case reports of role of antivirals in CMV and biliary atresia. We treated a 2 month old girl with biliary atresia who underwent portoduodenostomy at 2 and half months of age but continued to have jaundice (bilirubin = 23.6 mg/dl) even after 1 month of Kasai's surgery and subsequently was treated with valganciclovir for 6 weeks following which her jaundice resolved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796690     DOI: 10.1007/s13312-012-0092-7

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  3 in total

Review 1.  Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?

Authors:  Mark Davenport
Journal:  Pediatr Surg Int       Date:  2017-09-22       Impact factor: 1.827

Review 2.  Early and Peri-operative Prognostic Indicators in Infants Undergoing Hepatic Portoenterostomy for Biliary Atresia: a Review.

Authors:  Robert N Lopez; Chee Y Ooi; Usha Krishnan
Journal:  Curr Gastroenterol Rep       Date:  2017-04

Review 3.  Detection of Cytomegalovirus Infection in Infants with Biliary Atresia: A Meta-analysis.

Authors:  Sagad Omer Obeid Mohamed; Almutasim B E Elhassan; Ibrahim H E Elkhidir; Almigdad H M Ali; Mohamed Elata Hassan Elbathani; Osman Omer Ali Abdallah; Asaad Ahmed Mohamed Ahmed; Abazr A H Ibrahim; Mohammed Suliman Tawer Salman; Mahmoud Elnil; Mazin A M Elhassan; Abdelhamid Ibrahim Hassan Abuzied
Journal:  Avicenna J Med       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.